Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2021 | Colorectal Cancer | Retraction Note

Retraction Note: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance

Authors: Shan Zhou, Jinping Lu, Yuejin Li, Chan Chen, Yongqiang Cai, Gongjun Tan, Zhengke Peng, Zhenlin Zhang, Zigang Dong, Tiebang Kang, Faqing Tang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2021

Excerpt

Retraction Note: J Exp Clin Cancer Res 37, 284 (2018) …

Tang F, Wang D, Duan C, et al. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. J Biol Chem. 2009;284(40):27456–66. https://doi.org/10.1074/jbc.M109.033795.CrossRefPubMedPubMedCentral

Huang D, Li Y, Liu N, et al. Identification of novel signaling components in N,N’-Dinitrosopiperazine-mediated metastasis of nasopharyngeal Carcinoma by quantitative phosphoproteomics. BMC Cancer. 2014;14:243. https://doi.org/10.1186/1471-2407-14-243.CrossRefPubMedPubMedCentral

Tan G, Tang X, Huang D, Li Y, Liu N, Peng Z, et al. Dinitrosopiperazine-mediated phosphorylated-proteins are involved in nasopharyngeal carcinoma metastasis. International Journal of Molecular Sciences. 2014;15:20054–71.CrossRef

Peng Z, Liu N, Huang D, Duan C, Li Y, Tang X, et al. N,N'-dinitrosopiperazine–mediated heat-shock protein 70-2 expression is involved in metastasis of nasopharyngeal carcinoma. PLoS ONE. 2013;8(5):e62908. https://doi.org/10.1371/journal.pone.0062908.CrossRefPubMedPubMedCentral

Tang F, Zou F, Peng Z, et al. N,N'-dinitrosopiperazine-mediated ezrin protein phosphorylation via activation of Rho kinase and protein kinase C is involved in metastasis of nasopharyngeal carcinoma 6-10B cells. J Biol Chem. 2011;286(42):36956–67. https://doi.org/10.1074/jbc.M111.259234.CrossRefPubMedPubMedCentral

Title: Retraction Note: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance
Authors: Shan Zhou
Jinping Lu
Yuejin Li
Chan Chen
Yongqiang Cai
Gongjun Tan
Zhengke Peng
Zhenlin Zhang
Zigang Dong
Tiebang Kang
Faqing Tang
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Colorectal Cancer
Colorectal Cancer
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2021
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-021-02204-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155

Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma

Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology

C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer